Skip to main content

Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene

  • Research Report
  • Chapter
  • First Online:
JIMD Reports - Case and Research Reports, 2012/4

Part of the book series: JIMD Reports ((JIMD,volume 7))

Abstract

Glycogen Storage Disease type III (GSD III) is an autosomal recessive disorder in which a mutation in the AGL gene causes deficiency of the glycogen debranching enzyme. In childhood, it is characterized by hepatomegaly, keto-hypoglycemic episodes after short periods of fasting, and hyperlipidemia. In adulthood, myopathy, cardiomyopathy, and liver cirrhosis are the main complications. To determine the genotype of the GSD III patients (n = 14) diagnosed and treated in our center, mutation analysis was performed by either denaturing gradient gel electrophoresis or full gene sequencing. We developed, validated and applied both methods, and in all patients a mutation was identified on both alleles. Five novel pathogenic mutations were identified in seven patients, including four missense mutations (c.643G>A, p.Asp215Asn; c.655A>G, p.Asn219Asp; c.1027C>T, p.Arg343Trp; c.1877A>G, p.His626Arg) and one frameshift mutation (c.3911delA, p.Asn1304fs). The c.643G>A, p.Asp215Asn mutation is related with type IIIa, as this mutation was found homozygously in two type IIIa patients. In addition to five novel mutations, we present new genotype–phenotype relationships for c.2039G>A, p.Trp680X; c.753_756delCAGA, p.Asp251fs; and the intron 32 c.4260-12A>G splice site mutation. The p.Trp680X mutation was found homozygously in four patients, presenting a mild IIIa phenotype with mild skeletal myopathy, elevated CK values, and no cardiomyopathy. The p.Asp251fs mutation was found homozygously in one patient presenting with a severe IIIa phenotype, with skeletal myopathy, and severe symptomatic cardiomyopathy. The c.4260-12A>G mutation was found heterozygously, together with the p.Arg343Trp mutation in a severe IIIb patient who developed liver cirrhosis and hepatocellular carcinoma, necessitating an orthotopic liver transplantation.

Competing interests: None declared

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akazawa H, Kuroda T, Kim S, Mito H, Kojo T, Shimada K (1997) Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18:532–533

    Article  PubMed  CAS  Google Scholar 

  • Bao Y, Dawson TL Jr, Chen YT (1996) Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5’ flanking region. Genomics 38:155–165

    Article  PubMed  CAS  Google Scholar 

  • Bao Y, Yang BZ, Dawson TL Jr, Chen YT (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 15:389–398

    Article  Google Scholar 

  • Cheng A, Zhang M, Okubo M, Omichi K, Saltiel AR (2009) Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions. Hum Mol Genet 18:2045–2052

    Article  PubMed  CAS  Google Scholar 

  • Ding JH, De Barsy T, Brown BI, Coleman RA, Chen YT (1990) Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116:95–100

    Article  PubMed  CAS  Google Scholar 

  • Goldstein JL, Austin SL, Boyette K, Kanaly A, Veerapandiyan A, Rehder C, Kishnani PS, Bali DS (2010) Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III. Genet Med 12:424–430

    Article  PubMed  CAS  Google Scholar 

  • Haagsma EB, Smit GPA, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ (1997) Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 25:537–540

    Article  PubMed  CAS  Google Scholar 

  • Hayes VM, Wu Y, Osinga J, Mulder IM, van der Vlies P, Elfferich P, Buys CH, Hofstra RM (1999) Improvements in gel composition and electrophoretic conditions for broad-range mutation analysis by denaturing gradient gel electrophoresis. Nucleic Acids Res 27:e29

    Article  PubMed  CAS  Google Scholar 

  • Hobson-Webb LD, Austin SL, Bali DS, Kishnani PS (2010) The electrodiagnostic characteristics of glycogen storage disease type III. Genet Med 12:440–445

    Article  PubMed  CAS  Google Scholar 

  • Lam CW, Lee AT, Lam YY, Wong TW, Mak TW, Fung WC, Chan KC, Ho CS, Tong SF (2004) DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese. Mol Genet Metab 83:271–275

    Article  PubMed  CAS  Google Scholar 

  • Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV (1997) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79:834–838

    Article  PubMed  CAS  Google Scholar 

  • Liu W, Madsen NB, Braun C, Withers SG (1991) Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry 30:1419–1424

    Article  PubMed  CAS  Google Scholar 

  • Lucchiari S, Pagliarani S, Salani S, Filocamo M, Di Rocco M, Melis D, Rodolico C, Musumeci O, Toscano A, Bresolin N, Comi GP (2006) Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL. Hum Mutat 27:600–601

    Article  PubMed  CAS  Google Scholar 

  • Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1225

    Article  Google Scholar 

  • Newgard CB, Hwang PK, Fletterick RJ (1989) The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol 24:69–99

    Article  PubMed  CAS  Google Scholar 

  • Okubo M, Horinishi A, Nakamura N, Aoyama Y, Hashimoto M, Endo Y, Murase T (1998) A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 102:1–5

    Article  PubMed  CAS  Google Scholar 

  • Santer R, Kinner M, Steuerwald U, Kjaergaard S, Skovby F, Simonsen H, Shaiu WL, Chen YT, Schneppenheim R, Schaub J (2001) Molecular genetic basis and prevalence of glycogen storage disease type IIIa in the Faroe Islands. Eur J Hum Genet 9:388–391

    Article  PubMed  CAS  Google Scholar 

  • Shaiu WL, Kishnani PS, Shen J, Liu HM, Chen YT (2000) Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease. Mol Genet Metab 69:16–23

    Article  PubMed  CAS  Google Scholar 

  • Shen J, Bao Y, Liu HM, Lee PJ, Leonard JV, Chen YT (1996) Mutations in Exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98:352–357

    Article  PubMed  CAS  Google Scholar 

  • Shen J, Bao Y, Chen YT (1997) A nonsense mutation due to a single base insertion in the 3'-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa. Hum Mutat 9:37–40

    Article  PubMed  CAS  Google Scholar 

  • Shen JJ, Chen YT (2002) Molecular characterization of glycogen storage disease type III. Curr Mol Med 2:167–175

    Article  PubMed  CAS  Google Scholar 

  • Smit GPA, Rake JP, Akman HO, DiMauro S (2006) The glycogen storage diseases and related disorders. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH (eds) Inborn metabolic diseases: diagnosis and treatment. Springer Medizin Verlag, Heidelberg, pp 103–116

    Google Scholar 

  • Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95–102

    Article  PubMed  CAS  Google Scholar 

  • Yang-Feng TL, Zheng K, Yu J, Yang BZ, Chen YT, Kao FT (1992) Assignment of the human glycogen debrancher gene to chromosome 1p22. Genomics 13:931–934

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Prof. René Santer of the University Clinic Hamburg, Germany, for providing the DNA samples for the validation of our methods.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christiaan P Sentner .

Editor information

Editors and Affiliations

Additional information

Communicated by: Francois Feillet

Appendices

Synopsis

GSD III is characterized by a large clinical and genotypical heterogeneity, which makes the establishment of clear genotype-phenotype relationships difficult.

Conflicts of Interest

None declared.

Rights and permissions

Reprints and permissions

Copyright information

© 2012 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sentner, C.P., Vos, Y.J., Niezen-Koning, K.N., Mol, B., Smit, G.P.A. (2012). Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene. In: Brown, G., Morava, E., Peters, V., Gibson, K., Zschocke, J. (eds) JIMD Reports - Case and Research Reports, 2012/4. JIMD Reports, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_134

Download citation

  • DOI: https://doi.org/10.1007/8904_2012_134

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-32441-3

  • Online ISBN: 978-3-642-32442-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics